September 8, 2014 — Esaote North America announced its new MyLab Six ultrasound system has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and is now available for sale in the United States.

September 8, 2014 — Eizo Inc. expanded its U.S. Food and Drug Administration (FDA) 510(k)-cleared large monitor system with the addition of the RadiForce LS580W monitor and LMM0802 large monitor manager for interventional radiology and surgical suites.

The clinical nurse educator working in the adjacent lab was called to assist and made the decision to use the LUCAS 2 mechanical chest compression device to provide automatic external chest compressions. The radiolucent carbon fiber backboard was placed under Vanessa’s shoulders and the piston/suction cup placed over her chest. Once started, the LUCAS 2 applied continuous chest compressions of at least 5 centimeters at a consistent rate of 100 or more compressions per minute.

After several years of trials and increasing clinical use, transcatheter aortic valve replacement (TAVR) has reached a tipping point. It is quickly becoming the standard of care for ill patients suffering from aortic valve stenosis who are not eligible for open heart surgery. Implemented successfully, TAVR procedures improve outcomes and quality of life for patients while reducing costs for hospitals. 

Covidien TurboHawk Clinical Study Directional Atherectomy Effective PAD Therapy

Directional atherectomy is safe and effective as a frontline therapy for the treatment of peripheral arterial disease (PAD), according to a landmark Covidien study published online in the Journal of American College of Cardiology, Cardiovascular Interventions (JACC CI).

St. John Hospital currently performs about 2,000 percutaneous coronary and peripheral interventions and 400 open-heart surgeries, including minimally invasive and robotic surgery. With a goal to create a full structural heart program that answers its patients many needs, St. John Hospital recently created a hybrid operating room (OR). Among the challenges were deciding where to put the room, what procedures would be performed and what equipment would be necessary.

 

The U.S, Food and Drug Administration (FDA) has cleared MicroVention Inc.’s Low-Profile Visualized Intraluminal Support Device (LVIS and LVIS Jr.), which is a stent and delivery system used to treat certain brain aneurysms.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now